ImportRefusal LogoImportRefusal

Artron Laboratories, Inc.

⚠️ High Risk

FEI: 3005445066 • Burnaby, British Columbia • CANADA

FEI

FEI Number

3005445066

📍

Location

Burnaby, British Columbia

🇨🇦

Country

CANADA
🏢

Address

3938 North Fraser Way, , Burnaby, British Columbia, Canada

High Risk

FDA Import Risk Assessment

59.3
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

38
Total Refusals
6
Unique Violations
11/7/2024
Latest Refusal
12/18/2007
Earliest Refusal

Score Breakdown

Violation Severity
60.3×40%
Refusal Volume
58.9×30%
Recency
76.2×20%
Frequency
22.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

50828×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

11817×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2375×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

3415×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

32802×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

Refusal History

DateProductViolationsDivision
11/7/2024
83QYTOVER-THE-COUNTER COVID-19 ANTIGEN TEST
508NO 510(K)
Division of Southeast Imports (DSEI)
11/9/2023
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of Southeast Imports (DSEI)
10/19/2022
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of Southeast Imports (DSEI)
4/8/2022
83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES
237NO PMA
508NO 510(K)
Division of Southeast Imports (DSEI)
3/8/2022
83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES
508NO 510(K)
Division of Southeast Imports (DSEI)
2/24/2022
83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES
237NO PMA
Division of Northern Border Imports (DNBI)
2/18/2022
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of Southeast Imports (DSEI)
1/27/2022
83QMNCOVID-19 MULTI-ANALYTE ANTIGEN DEVICE
508NO 510(K)
Division of Southeast Imports (DSEI)
12/9/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
508NO 510(K)
Division of Southeast Imports (DSEI)
11/4/2020
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
118NOT LISTED
237NO PMA
508NO 510(K)
Division of Southeast Imports (DSEI)
10/5/2020
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of Southeast Imports (DSEI)
9/14/2020
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of Southeast Imports (DSEI)
9/11/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
237NO PMA
508NO 510(K)
Division of Southeast Imports (DSEI)
7/25/2020
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of Southeast Imports (DSEI)
6/29/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
508NO 510(K)
Division of Southeast Imports (DSEI)
6/25/2020
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of Southeast Imports (DSEI)
6/24/2020
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of Southeast Imports (DSEI)
6/18/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
508NO 510(K)
Division of Southeast Imports (DSEI)
5/6/2020
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
336INCONSPICU
508NO 510(K)
Division of Southeast Imports (DSEI)
4/23/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
508NO 510(K)
Division of Southeast Imports (DSEI)
4/21/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
118NOT LISTED
3280FRNMFGREG
508NO 510(K)
Division of Southeast Imports (DSEI)
9/21/2018
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
3280FRNMFGREG
341REGISTERED
Division of Southeast Imports (DSEI)
5/10/2018
91MVOKIT, TEST, MULTIPLE DRUGS OF ABUSE, OVER THE COUNTER
118NOT LISTED
508NO 510(K)
Division of Southeast Imports (DSEI)
5/10/2018
88NJTIMMUNOHISTOCHEMISTRY REAGENTS AND KITS
118NOT LISTED
508NO 510(K)
Division of Southeast Imports (DSEI)
5/10/2018
88NJTIMMUNOHISTOCHEMISTRY REAGENTS AND KITS
118NOT LISTED
508NO 510(K)
Division of Southeast Imports (DSEI)
5/10/2018
88NJTIMMUNOHISTOCHEMISTRY REAGENTS AND KITS
118NOT LISTED
508NO 510(K)
Division of Southeast Imports (DSEI)
4/21/2016
82MZFTEST, HIV DETECTION
118NOT LISTED
237NO PMA
Cincinnati District Office (CIN-DO)
5/8/2015
82DDGTRANSFERRIN, ANTIGEN, ANTISERUM, CONTROL
118NOT LISTED
508NO 510(K)
New Orleans District Office (NOL-DO)
5/8/2015
75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN
118NOT LISTED
508NO 510(K)
New Orleans District Office (NOL-DO)
5/8/2015
75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN
118NOT LISTED
508NO 510(K)
New Orleans District Office (NOL-DO)
4/21/2015
81MVUREAGENTS, SPECIFIC, ANALYTE
118NOT LISTED
Division of Southeast Imports (DSEI)
4/21/2015
81MVUREAGENTS, SPECIFIC, ANALYTE
118NOT LISTED
Division of Southeast Imports (DSEI)
7/5/2013
82NTWSYSTEM, BLOOD COLLECTION, RNA STABILIZATION, RNA PURIFICATION, RT-PCR MOLECULAR DIAGNOSTIC TEST
341REGISTERED
Florida District Office (FLA-DO)
4/13/2012
91LDJENZYME IMMUNOASSAY, CANNABINOIDS
118NOT LISTED
341REGISTERED
San Francisco District Office (SAN-DO)
4/13/2012
91DJPRADIOIMMUNOASSAY, AMPHETAMINE
118NOT LISTED
341REGISTERED
San Francisco District Office (SAN-DO)
4/13/2012
91DLTHEMAGGLUTINATION, OPIATES
118NOT LISTED
341REGISTERED
San Francisco District Office (SAN-DO)
9/30/2010
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
118NOT LISTED
Seattle District Office (SEA-DO)
12/18/2007
82MZFTEST, HIV DETECTION
118NOT LISTED
508NO 510(K)
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Artron Laboratories, Inc.'s FDA import refusal history?

Artron Laboratories, Inc. (FEI: 3005445066) has 38 FDA import refusal record(s) in our database, spanning from 12/18/2007 to 11/7/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Artron Laboratories, Inc.'s FEI number is 3005445066.

What types of violations has Artron Laboratories, Inc. received?

Artron Laboratories, Inc. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Artron Laboratories, Inc. come from?

All FDA import refusal data for Artron Laboratories, Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.